CYRX | CryoPortNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$16.45
+$0.22 (+1.36%)

CryoPort (CYRX) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.

The 50 SMA has sat above the 200 on the daily since May 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits between the 50 and the 200; on the weekly it is above both.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
between the two $16.45 vs 50 $16.94 / 200 $13.36
Projection
No cross projected
Test
No active test
Last cross
Golden cross 8 May 2026 ยท projected 27 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $17.29 vs 50 $12.71 / 200 $12.35
Projection
No cross projected
Test
Cross test window open, no test bar yet
Last cross
Golden cross week of 12 Oct 2026 ยท projected 18 bars out

4-hour as of 3 Nov 13:30 ET

Price
between the two $16.53 vs 50 $17.44 / 200 $16.21
Projection
No cross projected
Test
No active test
Last cross
Golden cross 24 Apr 2026 ยท projected 28 bars out

Cross history

27
crosses on record since 2018
14 golden13 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
week of 12 Oct 2026Golden moderateweekly18 bars outActive Cross Test
8 May 2026Golden moderatedaily27 bars outNot tested
24 Apr 2026Golden4-hour28 bars outNot tested
27 Mar 2026Death moderatedaily28 bars out2 bar cross test
20 Feb 2026Death4-hour24 bars outNot tested

About CYRX

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$9.9M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.